CLEAR Outcomes Subanalysis
January 24, 2024 | Paul Ridker and C. Michael Gibson discuss whether residual inflammatory risk or residual cholesterol risk is a more effective predictor of CV events among patients treated with statins. |
TCTMD Talking Points
2024-01-24T17:00:00Z